The disability caused by stroke is a serious public health problem that causes a heavy burden to the society. The convalescence of stroke disability is the key stage of functional recovery, but there is no effective drug treatment at present. In recent years, traditional Chinese medicine (TCM) has significant potential in the field of drug research and development. Based on the guidelines for the diagnosis and treatment of stroke recovery at home and abroad in recent years, combined with the current clinical research situation and potential problems of TCM research and development, this paper discussed the key link in the process of clinical research design, including clinical positioning, efficacy indicators, clinical test control, treatment course, and visiting perspective, and takes the clinical trial of Qizhi Tongluo capsule as an example to explain, aiming to provide objective and operable design elements for the majority of researchers in the field of TCM to carry out high-quality clinical research.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |